Serum levels of tumour associated glycoprotein (TAG 72) in patients with gynaecological malignancies.

Department of Gynecology, Catholic University, Rome, Italy.
British Journal of Cancer (Impact Factor: 4.84). 08/1990; 62(1):147-51. DOI: 10.1038/bjc.1990.248
Source: PubMed

ABSTRACT Serum levels of TAG 72 were measured in 726 serum samples from patients with benign and malignant gynaecological conditions in order to evaluate the clinical usefulness of TAG 72 alone or in combination with other tumour markers. Sixty-six per cent of patients with ovarian cancer showed abnormal concentrations of TAG 72 antigen. A good correlation was also found between serial TAG 72 values and the clinical course of disease during chemotherapy and follow-up. In cervical and endometrial cancer abnormal TAG 72 values occurred in 23% and 14% of cases, while none of the patients with breast cancer had abnormal TAG 72 levels. Among patients with benign disease only one out of 12 patients (8%) with benign ovarian tumours and one of 15 patients with uterine fibromyomatosis (7%) showed high TAG 72 serum levels. However, the determination of TAG 72 did not increase the sensitivity of CA 125 and squamous cell carcinoma antigen (SCC), in ovarian and cervical cancer, respectively. The systemic administration of recombinant interferon alpha-2b to 15 patients with ovarian cancer and different basal levels of TAG 72 did not increase serum levels of the antigen.

10 Reads
  • Journal of Clinical Endocrinology &amp Metabolism 04/1993; 76(4):1075-1079. DOI:10.1210/jc.76.4.1075 · 6.21 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: The serum glycan moieties of glycoproteins and the activities of glycosidases were analyzed in order to elucidate the metabolism of glycoprotein in uterine cervical cancer. Serum was collected from patients at different stages of cervical cancer before and after treatment. The results were analyzed using Student's t-test. The glycan moieties such as sialic acid and fucose were significantly elevated even in the early stages of carcinoma, whereas a significant elevation in hexose and hexosamine levels was observed only in the advanced stages. Among the investigated lysosomal glycohydrolases, beta-D-galactosidase, N-acetyl-beta-D-glucosaminidase and alpha-L-fucosidase activities were elevated significantly at all stages except for stage I. The altered levels of glycoproteins and glycosidases were reduced to near-normal levels after radiotherapy. The levels of glycan moieties and the activities of glycosidases can be used as diagnostic markers to assess the stage of cancer and can be used as prognostic markers during therapy.
    International Journal of Gynecology & Obstetrics 02/1995; 48(1):49-54. DOI:10.1016/0020-7292(94)02247-X · 1.54 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: High levels of IL-6 were found in 50% of 114 patients with primary ovarian cancer. IL-6 sensitivity was lower than that of CA 125, and the combination of both assays did not increase the sensitivity of CA 125 alone. However, elevated IL-6 serum levels were correlated with a poor prognosis since patients with low IL-6 levels had a better survival than patients with high IL-6 levels (P = 0.0009). Multivariate analysis revealed that IL-6 positivity has an independent value.
    British Journal of Cancer 03/1995; 71(2):354-6. DOI:10.1038/bjc.1995.71 · 4.84 Impact Factor


10 Reads
Available from